TipRanks
Go Ultimate55% OFF

Seres Therapeutics (1S90) Balance Sheet

Seres Therapeutics Balance Sheet

Seres Therapeutics's total assets for Q2 2026 were $101.59M, a decrease of 13.63% from the previous quarter. DE:1S90 total liabilities were $67.05M for the fiscal quarter, a 26.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 138.19M$ 139.81M$ 358.60M$ 348.78M$ 354.86M
$ 93.97M$ 126.03M$ 403.46M$ 338.00M$ 223.35M
$ 44.22M$ 13.78M$ -44.86M$ 10.78M$ 131.51M

Currency in USD

Seres Therapeutics Debt to Assets

0150M300M450M40 %80 %120 %160 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets